Literature DB >> 12033377

Electrically modulated transdermal delivery of fentanyl.

Rajkumar Conjeevaram1, Ajay K Banga, Lei Zhang.   

Abstract

PURPOSE: Test to determine if iontophoresis and electroporation, alone or in combination, can be used for rapid and modulated delivery of fentanyl.
METHODS: Fentanyl citrate (5 mg/ml) dissolved in pH 4.0 citrate buffer was delivered in vitro across human epidermis. For iontophoresis. a current of 0.5 mA/cm2 was applied for 5 h, using silver/silver chloride electrodes. Electroporation protocol consisted of applying 15 exponential pulses of 500V (applied voltage) and 200 msec duration at the rate of 1 pulse per minute at time zero and, in some cases, repeating at 1.5 and 2.5 h.
RESULTS: There was no measurable permeation of fentanyl through human epidermis under passive conditions. A significant flux (about 80 microg/cm2-hr) was achieved using iontophoresis and decreased once the current was turned off. A 4-fold higher flux and shorter lag time was observed with electroporation as compared to iontophoresis. The flux was found to recover quickly (within 1 h) following pulsing. Modulation of transdermal delivery of fentanyl was demonstrated by both iontophoresis and electroporation.
CONCLUSIONS: Electrically assisted transdermal delivery of fentanyl significantly increased transport compared to passive delivery. Also, rapid and modulated delivery was shown to be feasible by programming the electrical parameters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033377     DOI: 10.1023/a:1015135426838

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  The importance of electric field distribution for effective in vivo electroporation of tissues.

Authors:  D Miklavcic; K Beravs; D Semrov; M Cemazar; F Demsar; G Sersa
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

2.  Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.

Authors:  S D Roy; M Gutierrez; G L Flynn; G W Cleary
Journal:  J Pharm Sci       Date:  1996-05       Impact factor: 3.534

3.  Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients.

Authors:  W Korte; N de Stoutz; R Morant
Journal:  J Pain Symptom Manage       Date:  1996-03       Impact factor: 3.612

4.  Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation.

Authors:  R Vanbever; G Langers; S Montmayeur; V Préat
Journal:  J Control Release       Date:  1998-01-02       Impact factor: 9.776

5.  Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current.

Authors:  S K Gupta; K J Bernstein; H Noorduin; A Van Peer; G Sathyan; R Haak
Journal:  J Clin Pharmacol       Date:  1998-10       Impact factor: 3.126

6.  Transdermal fentanyl: clinical development in the United States.

Authors:  M A Simmonds
Journal:  Anticancer Drugs       Date:  1995-04       Impact factor: 2.248

Review 7.  Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy.

Authors:  M A Southam
Journal:  Anticancer Drugs       Date:  1995-04       Impact factor: 2.248

8.  Guidelines for the clinical use of transdermal fentanyl.

Authors:  R Payne; S Chandler; M Einhaus
Journal:  Anticancer Drugs       Date:  1995-04       Impact factor: 2.248

9.  Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial.

Authors:  R Miguel; J M Kreitzer; D Reinhart; P S Sebel; J Bowie; G Freedman; J B Eisenkraft
Journal:  Anesthesiology       Date:  1995-09       Impact factor: 7.892

10.  The iontophoresis of fentanyl citrate in humans.

Authors:  M A Ashburn; J Streisand; J Zhang; G Love; M Rowin; S Niu; J K Kievit; J R Kroep; M J Mertens
Journal:  Anesthesiology       Date:  1995-05       Impact factor: 7.892

View more
  3 in total

1.  Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.

Authors:  Anne-Rose Denet; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

2.  Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery.

Authors:  Ayyappa Chaturvedula; Dipty P Joshi; Carter Anderson; Russ Morris; Walter L Sembrowich; Ajay K Banga
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

3.  Enhanced transdermal delivery of granisetron by using iontophoresis.

Authors:  Prabhakar Panzade; Ashish Heda; Prashant Puranik; Mayur Patni; Vipul Mogal
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.